Crinetics Pharmaceuticals, Inc. CRNX
- atumelnant — Congenital Adrenal Hyperplasia Phase 3
- atumelnant — Adrenal Crisis Phase 2
Home › Targets › melanocortin receptor
melanocortin receptor (1 companies · 2 programs)
Companies with an active program directed at melanocortin receptor.